> ## Content Index
> Fetch the complete content index at: https://thevoiceofenablingtechnology.pmbofficial.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA clears software that helps home sleep tests estimate actual sleep
- URL: https://thevoiceofenablingtechnology.pmbofficial.com/live-wire/fda-clears-software-home-sleep-tests-estimate-actual-sleep/
- Published: 2026-11-04T20:43:06.000Z
- Updated: 2026-11-04T20:43:06.000Z
- Description: Neurotronics’ Sleep Analysis Module estimates sleep time from the pulse oximeter signal a home sleep test already collects, with no extra sensor.
- Author: Precious “Preciosa” Myers-Brown
- Tags: Live Wire, #live-wire, #wire-technology

On November 3, 2026, Neurotronics, a Nihon Kohden company, announced that the U.S. Food and Drug Administration has cleared its Sleep Analysis Module, called SAM. SAM is software that estimates how long a person actually slept, using the signal a pulse oximeter is already collecting during a home sleep test. It is meant to help clinicians evaluate sleep disorders.

Here’s why that matters. Many home sleep apnea tests count the whole time the recorder is running, because measuring sleep itself has usually required extra sensors that track brain, eye and muscle activity. Sleep apnea severity is judged by breathing events per hour of sleep, so counting the whole recording can include hours a person spent awake. SAM lets clinicians use estimated sleep time instead, without adding sensors or changing how the test is set up.

SAM will first be built into Neurotronics’ Polysmith software for studies recorded with its NomadAir home sleep apnea test. It requires a prescription, is for adults 18 and older, and is used by or under the supervision of a clinician. Neurotronics says it is still completing the integration and verification work required before commercial release. The company also notes that SAM isn’t meant for use when full sleep staging is possible, and isn’t meant to be the sole or primary basis for diagnosing any sleep disorder.

What I like here is that it asks nothing more of the person. There’s no new sensor and no change to the setup, just more value from what they’re already wearing. Less burden is a form of access. For older adults, and for anyone who finds a lab visit hard to manage, a simpler home test can be the difference between getting evaluated and putting it off.

## Tech Equity

A diagnosis should reflect a person’s actual night, not just how long the machine was running. When a test gets more from what is already being collected, without adding anything to a person’s night, more people can get a clearer answer on fairer terms.

Sources: [Neurotronics announcement, November 3, 2026](https://www.businesswire.com/news/home/20261103172377/en/Neurotronics-Receives-FDA-Clearance-for-Sleep-Analysis-Module-Advancing-Nihon-Kohdens-AIML-Enabled-Sleep-Analysis-Capabilities?ref=thevoiceofenablingtechnology.pmbofficial.com)